Company
Cingulate Inc. (CING)
Standardized SEC financial data for Cingulate Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001862150 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-894.8%
Free cash flow
-$17.4M
Current ratio
1.16×
EPS (diluted)
$-4.44
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $5.1M | $8.4M | $9.0M | $15.5M | $9.4M | $9.8M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.2M | $16.5M | $5.4M | $52K | $12.2M | $11.0M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$6.8M | -$10.4M | -$15.9M | -$15.0M | -$18.5M | -$17.2M |
| Capital expenditures |
Get CING data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CING/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CING/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"